Slice Of Healthcare

#345 - Sharon Rogers, CEO at AmyriAD Therapeutics

Informações:

Sinopsis

Our Guest: Sharon Rogers, CEO at AmyriAD TherapeuticsWhat you'll get out of this episode: Rogers' background An overview of AmyriAD Therapeutics  The company's lead compound, AD101 Their clinical trials & what they're showing Launching a Phase 3 Study What's next? Our sponsors for this episode are Sage Growth Partners & FlipMDSage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartnersFlipMD is an open, competitive marketplace of physicians only offering their consulting services to a wide range of client industries. The ultimate goal of flipMD is to be the best source of physician talent for any industry. The platform is very simple to